Polo-like kinase-1 mediates hepatitis C virus-induced cell migration, a drug target for liver cancer.

Life Sci Alliance · 2023 · PMC10468647 · PMID 37648284

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

There was a dose-dependent reduction in phospho-PLK1 and total PLK1, with a nonsignificant trend towards reduced PLK1 activation (pPLK1/PLK1) (shown in Fig 4D ).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.